Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation

Clinical trial NCT05335434 · RECRUITING

Trial details

NCT number: NCT05335434
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Myeloablative Allogeneic Hematopoietic Cell Transplantation Intraoral Photobiomodulation Therapy Oral Mucositis Mucosal Ulcer

Start date: 2022-06-10
Primary completion: 2026-06-20
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.